PL379516A1 - Nowe związki i kompozycje zawierające sterole i/lub stanole oraz inhibitory biosyntezy cholesterolu, oraz ich zastosowanie w leczeniu i zapobieganiu różnych chorób i stanów chorobowych - Google Patents
Nowe związki i kompozycje zawierające sterole i/lub stanole oraz inhibitory biosyntezy cholesterolu, oraz ich zastosowanie w leczeniu i zapobieganiu różnych chorób i stanów chorobowychInfo
- Publication number
- PL379516A1 PL379516A1 PL379516A PL37951604A PL379516A1 PL 379516 A1 PL379516 A1 PL 379516A1 PL 379516 A PL379516 A PL 379516A PL 37951604 A PL37951604 A PL 37951604A PL 379516 A1 PL379516 A1 PL 379516A1
- Authority
- PL
- Poland
- Prior art keywords
- stanols
- sterols
- diseases
- compositions
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61545603A | 2003-07-09 | 2003-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL379516A1 true PL379516A1 (pl) | 2006-10-02 |
Family
ID=34062381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL379516A PL379516A1 (pl) | 2003-07-09 | 2004-07-09 | Nowe związki i kompozycje zawierające sterole i/lub stanole oraz inhibitory biosyntezy cholesterolu, oraz ich zastosowanie w leczeniu i zapobieganiu różnych chorób i stanów chorobowych |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1644399A2 (no) |
JP (1) | JP2007525470A (no) |
KR (1) | KR20060052792A (no) |
CN (1) | CN1832957A (no) |
AU (1) | AU2004255285A1 (no) |
BR (1) | BRPI0412439A (no) |
CA (1) | CA2531836A1 (no) |
MX (1) | MXPA06000326A (no) |
NO (1) | NO20060632L (no) |
NZ (1) | NZ545087A (no) |
PL (1) | PL379516A1 (no) |
RU (1) | RU2006103797A (no) |
WO (1) | WO2005005453A2 (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
KR100886466B1 (ko) * | 2006-09-12 | 2009-03-04 | (주)한국씨엔에스팜 | 신규한 스티그마스테롤 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법, 및 이를 포함하는 비만억제 또는 고지혈증 예방 및 치료용 조성물 |
DE102007005045B4 (de) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007063671A1 (de) | 2007-11-13 | 2009-06-25 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
EP2470552B1 (en) | 2009-08-26 | 2013-11-13 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CA2872751A1 (en) | 2012-05-07 | 2013-11-14 | The Regents Of The University Of California | Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis |
KR20140081339A (ko) * | 2012-12-21 | 2014-07-01 | 부경대학교 산학협력단 | 푸코스테롤을 유효성분으로 포함하는 퇴행성 신경질환 예방 또는 치료용 약제학적 조성물 |
CN105263500A (zh) | 2013-05-02 | 2016-01-20 | 加利福尼亚大学董事会 | 骨选择性成骨性氧固醇-骨靶向剂 |
US9611288B2 (en) | 2014-12-09 | 2017-04-04 | Warsaw Orthopedic, Inc. | Compounds and methods involving sterols |
CN104434927A (zh) * | 2014-12-16 | 2015-03-25 | 吉林农业大学 | 丙二酸双环戊烷并多氢菲酯b在制备降血压药物中的应用 |
US10632230B2 (en) | 2015-07-10 | 2020-04-28 | Warsaw Orthopedic, Inc. | Implants having a high drug load of an oxysterol and methods of use |
US9987289B2 (en) | 2015-07-10 | 2018-06-05 | Warsaw Orthopedic, Inc. | Slow release oxysterols and methods of use |
US9877836B2 (en) | 2015-07-10 | 2018-01-30 | Warsaw Orthopedic, Inc. | Compression resistant implants including an oxysterol and methods of use |
CN105087609B (zh) * | 2015-08-19 | 2018-10-23 | 四川大学 | 一种重组慢病毒及其在制备治疗可卡因成瘾的药物中的用途 |
CN105055404B (zh) * | 2015-08-19 | 2017-07-18 | 四川大学 | Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途 |
US10688222B2 (en) | 2016-11-21 | 2020-06-23 | Warsaw Orthopedic, Inc. | Lyophilized moldable implants containing an oxysterol |
US11384114B2 (en) | 2016-12-09 | 2022-07-12 | Warsaw Orthopedic, Inc. | Polymorphic forms of an oxysterol and methods of making them |
US10434106B2 (en) | 2017-05-19 | 2019-10-08 | Warsaw Orthopedic, Inc. | Oxysterol-statin compounds for bone growth |
US11464888B2 (en) | 2017-06-12 | 2022-10-11 | Warsaw Orthopedic, Inc. | Moldable formulations containing an oxysterol in an acellular tissue matrix |
KR102139994B1 (ko) * | 2017-10-25 | 2020-07-31 | 대구대학교 산학협력단 | 스티그마스테롤을 유효성분으로 함유하는 골다공증의 예방 또는 치료용 약학적 조성물 |
CN113143935B (zh) * | 2021-02-01 | 2022-10-11 | 广东药科大学 | 豆甾醇在制备改善心肌肥厚的药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5216015A (en) * | 1991-02-05 | 1993-06-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having hypocholesterolemic properties |
KR100711861B1 (ko) * | 1999-06-23 | 2007-04-25 | 포비스 메디-테크 인코포레이티드 | 심혈관질환을 치료하거나 예방하기 위한 피토스테롤 또는 피토스타놀과 아스코르브산의 결합체 및 그 용도 |
-
2004
- 2004-07-09 NZ NZ545087A patent/NZ545087A/en unknown
- 2004-07-09 KR KR1020067000470A patent/KR20060052792A/ko not_active Application Discontinuation
- 2004-07-09 BR BRPI0412439-1A patent/BRPI0412439A/pt not_active IP Right Cessation
- 2004-07-09 JP JP2006517922A patent/JP2007525470A/ja not_active Withdrawn
- 2004-07-09 EP EP04737936A patent/EP1644399A2/en not_active Withdrawn
- 2004-07-09 MX MXPA06000326A patent/MXPA06000326A/es unknown
- 2004-07-09 RU RU2006103797/04A patent/RU2006103797A/ru not_active Application Discontinuation
- 2004-07-09 WO PCT/CA2004/000999 patent/WO2005005453A2/en active Search and Examination
- 2004-07-09 CA CA002531836A patent/CA2531836A1/en not_active Abandoned
- 2004-07-09 PL PL379516A patent/PL379516A1/pl unknown
- 2004-07-09 AU AU2004255285A patent/AU2004255285A1/en not_active Abandoned
- 2004-07-09 CN CNA2004800228667A patent/CN1832957A/zh active Pending
-
2006
- 2006-02-09 NO NO20060632A patent/NO20060632L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007525470A (ja) | 2007-09-06 |
NO20060632L (no) | 2006-04-06 |
WO2005005453A2 (en) | 2005-01-20 |
CN1832957A (zh) | 2006-09-13 |
RU2006103797A (ru) | 2006-07-27 |
AU2004255285A1 (en) | 2005-01-20 |
MXPA06000326A (es) | 2006-03-30 |
WO2005005453A3 (en) | 2005-06-09 |
NZ545087A (en) | 2009-10-30 |
EP1644399A2 (en) | 2006-04-12 |
BRPI0412439A (pt) | 2006-09-05 |
KR20060052792A (ko) | 2006-05-19 |
CA2531836A1 (en) | 2005-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL379516A1 (pl) | Nowe związki i kompozycje zawierające sterole i/lub stanole oraz inhibitory biosyntezy cholesterolu, oraz ich zastosowanie w leczeniu i zapobieganiu różnych chorób i stanów chorobowych | |
PL376301A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 | |
HUP0302955A3 (en) | Hmg-coa reductase inhibitors, pharmaceutical compositions containing them and their use for treatment of cholesterol related diseases | |
EP1824842A4 (en) | INHIBITORS OF 11-HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHOD OF USE | |
HUP0303040A3 (en) | Compositions and methods for lowering plasma lipoprotein and risk factors of cardiovascular diseases | |
IL160630A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
PL370275A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
IL161733A0 (en) | Methods and compositions for therapeutic use of rna interference | |
AU2003265010A1 (en) | Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein | |
EP1469810A4 (en) | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISEASES RELATED TO AMYLOID-BETA PEPTIDE | |
IL164370A0 (en) | Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease | |
IL180737A0 (en) | Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions | |
IL172018A0 (en) | Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases | |
EP1773349A4 (en) | METHODS AND COMPOSITIONS FOR TREATING PREECLAMPSIA | |
EP1542664A4 (en) | METHODS AND COMPOSITIONS FOR TREATING MACULAR AND RETINAL DISORDERS | |
EP1691820A4 (en) | PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE | |
HUP0401687A3 (en) | Acylsulfonamides as inhibitors of steroid sulfatase and pharmaceutical compositions containing them | |
EP1562597A4 (en) | COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF MACULAR DEGENERATION AND METHODS OF USE THEREOF | |
AU2003285883A1 (en) | Methods and compositions for determining risk of treatment toxicity | |
EP1686973A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES | |
AU2003300176A8 (en) | Methods and compositions of ecdysozoan molt inhibition | |
GB0419175D0 (en) | Method of treatment and compositions | |
AU2003229335A8 (en) | Compositions and methods for treatment of wounds | |
GB0220225D0 (en) | Methods and compositions for treatment of akinesia | |
HK1096095A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |